Earnings Call · Q3 FY2024·2024-11-08

Q3 24EPS +26.32%·Rev n/aQ2 24EPS 0.00%·Rev n/aQ1 24EPS -15.79%·Rev n/aQ4 23EPS -55.56%·Rev n/a⚠ consensus missing

Apyx Medical Corp APYX

Jeremy Feffer — Investor Relations or Corporate Communications (inferred from role of introducing the call)

Charlie Goodwin — Chief Executive Officer

Stavros Vizirgianakis — Executive Chairman of the Board of Directors

Matt Hill — Chief Financial Officer

+24.6%1d on move date+24.2% vs SPY3d+12.3%5d+5.7%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more APYX calls or request research access.

More APYX calls Browse calls Request research access